Gå direkt till innehåll
Delphi advisor to Galena Biopharma, Inc. in the acquisition of the drug Abstral in the U.S. from Orexo AB

Pressmeddelande -

Delphi advisor to Galena Biopharma, Inc. in the acquisition of the drug Abstral in the U.S. from Orexo AB

Delphi has assisted Galena Biopharma Inc. and its U.S. advisor in the acquisition of Abstral in the U.S. from Orexo AB. Galena Biopharma is a biopharmaceutical company developing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. Abstral is the leading fast-acting fentanyl product in Europe with a turnover of 54 million USD in 2012. Abstral was approved in 2011 by the U.S. Drug Administration The Food and Drug Administration (FDA). In June 2012, Orexo AB announced that it had acquired the U.S. rights to the product of Prostrakan Group plc, as part of a restructuring of the global rights for Abstral.

Delphi's team, which was responsible for the Swedish legal advice, was led by Olof Myhrman, partner of Delphi's M&A group and Caroline Ygge, partner of Delphi's intellectual property group. The team also consisted of Elisabeth Eklund, partner in Delphi's EU and competition group, Mikael Knutsson, partner in Delphi's tax group, Henry Almström (intellectual property), Caroline Ekström (tax) and Eva Folkow (labour).


Contact:
Olof Myhrman
Partner/Advokat
Delphi
Ph. +46 709 25 25 59
email: olof.myhrman@delphi.se


Ämnen

Regioner


-------

Delphi is one of the foremost commercial law firms in Sweden. We help our clients with mergers and acquisitions. We advise them on matters of banking, finance and capital markets. We litigate at court and in arbitration and are acknowledged as being extremely competent in public procurement and environmental law.

Many of us are specialists in high-tech fields such as IT, intellectual property and life science. Our drive and our interest in technology and business probably explain, in part, our success. We are often praised for our commercial sense and our ability to understand the client’s business. 

Our clients are to be found primarily in Scandinavia, Europe and North America. But we also co-operate with law firms globally and regularly assist clients on international matters. We have a total workforce of 190, of which 140 are lawyers. We have offices in Stockholm, Göteborg, Malmö, Linköping and Norrköping.

 

 

Kontakter

Stefan Erhag

Stefan Erhag

Presskontakt Executive Partner +46 709 25 25 48

Delphi är en av de främsta affärsjuridiska byråerna i Sverige

Advokatfirman Delphi är en progressiv affärsjuridisk advokatbyrå med erkända specialister inom de flesta av affärsjuridikens områden. Vi är totalt cirka 210 medarbetare, varav ungefär 150 jurister. Våra kontor finns i Stockholm, Göteborg, Malmö och Linköping.

Genom att korsa djup affärsförståelse med nya smartare sätt att tänka, skräddarsyr vi vår service, expertis och erbjudanden efter våra klienters olika behov. Vi ger tydliga råd och rekommendationer baserade på varje klients unika affärsutmaning och är en strategisk samarbetspartner till våra klienter. Vi driver utvecklingen framåt och utmanar varandra, våra klienter och branschen med den bästa affären som mål.

Advokatfirman Delphi

Mäster Samuelsgatan 17, Box 1432
111 84 Stockholm
Sverige